Legal status Investigational PubChem CID 9806190 Formula C31H39NO5 Pubchem 9806190 | CAS Number 198414-31-2 UNII 1K9EYK92PQ Molar mass 505.65 g/mol ChemSpider ID 7981950 | |
 | ||
Synonyms CDB-4124; 17α-Acetoxy-21-methoxy-11β-[4-N,N-dimethylaminophenyl]-19-norpregna-4,9-diene-3,20-dione) | ||
How to pronounce telapristone
Telapristone (INN), as telapristone acetate (proposed trade names Proellex, Progenta; former code name CDB-4124), is an investigational selective progesterone receptor modulator (SPRM) being studied for the treatment of certain progesterone-sensitive conditions. It was originally developed by the National Institutes of Health (NIH), and as of 2012, is in phase II clinical trials for the treatment of uterine fibroids and endometriosis. In addition to its actions as an SPRM, telapristone also has some antiglucocorticoid activity.
References
Telapristone Wikipedia(Text) CC BY-SA